用甲福明治疗的糖尿病患者的维生素B缺乏:叙事性综述
Mazhar Salim Al Zoubi1, Rasha Al Kreasha1, Sarah Aqel1
1Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Irish journal of medical science
|February 21, 2024
概括
甲胺是一种常见的糖尿病药物,可以通过干扰其吸收来降低维生素B12水平. 使用时间和某些健康状况会增加患者出现这种缺陷的风险.
科学领域:
- 内分泌学 在内分泌学.
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲福明是一种广泛处方的口服低血糖药物,用于治疗2型糖尿病 (T2DM).
- 研究表明,在糖尿病患者中,甲福明的使用与降低维生素B12水平之间存在相关性.
- 了解这种关联对于有效管理T2DM至关重要.
研究的目的:
- 审查目前关于甲胺和维生素B12缺乏之间的联系的文献.
- 探索这种相互作用背后的拟议机制.
- 确定导致甲福明使用者的维生素B12缺乏症的个体风险因素.
主要方法:
- 出版报告的文献审查.
- 对拟议的生化机制进行分析.
- 识别和综合相关的风险因素.
主要成果:
- 梅特福林的主要机制涉及干扰依赖的维生素B12吸收.
- 维生素B12缺乏的风险增加与更高的甲福林剂量和更长的治疗时间有关.
- 诸如男性性别和某些慢性疾病 (T2DM,高脂血症,CAD,PCOD,肥胖症) 等因素与更高的缺乏症风险有关.
结论:
- 甲福明的使用与维生素B12缺乏有关,主要是由于肠道吸收受损.
- 甲福尔的持续时间和剂量以及并发症是显著的危险因素.
- 建议在接受甲福林治疗的患者中监测维生素B12水平,特别是那些有风险因素的患者.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
539
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
539
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Dipeptidyl Peptidase 4 Inhibitors
187
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
187
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Pathophysiology of Diabetes
935
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
935


